FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:751-753 August 14, 2008 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Weintraub, W. S. PubMed Citation

Twenty-five years ago, care for patients with symptomatic coronary artery disease centered on the selection and titration of antianginal medications. Percutaneous coronary intervention (PCI), which was limited at that time to balloon angioplasty, was an alternative. However, the risks associated with the procedure and the rate of restenosis largely relegated it to second-line therapy for patients who did not have a response to best medical therapy. Fast-forward to the present. Coronary stents have revolutionized PCI and have reduced the rate of complications and the need for repeat interventions. This advance has markedly altered clinicians' thresholds for considering PCI. Now, the . . . [Full Text of this Article]

Source Information

From the Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (E.D.P.); and the Denver Veterans Affairs Medical Center and University of Colorado Denver Health Sciences Center, Denver (J.S.R.).

Related Letters:

Quality of Life with PCI versus Medical Therapy in Stable Coronary Disease
Beltrame J. F., Tavella R., Cutri N., Rodriguez A. E., Maree A. O., Palacios I. F., Reppel M., Radke P. W., Schunkert H., Kinlay S., Brown R. A., Teirstein P. S., Kandzari D. E., Smith J., Weintraub W. S., Kolm P., Boden W. E., Peterson E. D., Rumsfeld J. S.
Extract | Full Text | PDF  
N Engl J Med 2008; 359:2289-2293, Nov 20, 2008. Correspondence

This article has been cited by other articles:

• Beltrame, J. F., Tavella, R., Cutri, N., Rodriguez, A. E., Maree, A. O., Palacios, I. F., Reppel, M., Radke, P. W., Schunkert, H., Kinlay, S., Brown, R. A., Teirstein, P. S., Kandzari, D. E., Smith, J., Weintraub, W. S., Kolm, P., Boden, W. E., Peterson, E. D., Rumsfeld, J. S. (2008). Quality of Life with PCI versus Medical Therapy in Stable Coronary Disease. NEJM 359: 2289-2293 [Full Text]  
• (2008). Health Status and Angina Relief Results from COURAGE. Journal Watch Cardiology 2008: 1-1 [Full Text]  
• (2008). Stenting vs. Medical Management of Stable Coronary Disease: More Outcomes from COURAGE. JWatch General 2008: 1-1 [Full Text]